Summary
A case of polyarthralgia and serological abnormalities after augmentation mammaplasty with saline-filled prostheses is reported. Although such systemic disease has been reported in relation to gel-filled implants, this type of syndrome is very rare in association with saline-filled implants. Possible etiopathogenic factors are suggested in order to find out the mechanism of systemic immunological disease when no silicone gel is present. Shearing of silicone dioxide molecules from the implant shell could possibly be associated with the development of adjuvant disease in the case reported. It is stressed, however, that no definite connection between silicone implants and human adjuvant disease has ever been demonstrated.
Similar content being viewed by others
References
Allison AC, Harington JS, Birbeck M (1966) An examination of the cytotoxic effects of silica on macrophages. J Exp Med 124:141
Ashley FL, Braley S, Rees TD et al (1967) The present status of silicone fluid in soft tissue augmentation. Plast Reconstr Surg 39:411
Baldwin CM, Kaplan EN (1983) Silicone-induced human adjuvant diseases? Ann Plast Surg 10:270
Ballantyne DL, Rees TD, Seidman I (1965) Silicone fluid: response to massive subcutaneous injections of dimethylpolysiloxane fluid in animals. Plast Reconstr Surg 36:330
Ben-Hur N, Ballantyne DL, Rees TD (1967) Local and systemic effects of dimethylpolysiloxane fluid in mice. Plast Reconstr Surg 39:423
Byron MA, Venning VA, Mowat AC (1984) Postmammaplasty human adjuvant disease. Br J Rheumatol 23:227
Delage C, Shane JJ, Johnson FB (1973) Mammary silicone granuloma. Arch Dermatol 108:104
Ellenbogen R, Rubin L (1975) Injectable fluid silicone therapy-human morbidity and mortality. JAMA 234:308
Endo LP, Edwards NL, Longley S, Danush RS (1986) Breast augmentation and arthritis: musculoskeletal symptoms after silicone mammaplasty (abstract). Arthritis Rheum 29 [Suppl]: S48
Endo LP, Edwards NL, Longley S, Corman LC, Panush RS (1987) Silicone and rheumatic diseases. Sem Arthritis Rheumatism 17:112
Fock KM, Freng PH, Tey BH (1984) Autoimmune disease developing after augmentation mammaplasty: report of three cases. J Rheumatol 11:98
Hausner RJ, Schoen FJ, Pierson KK (1978) Foreign body reaction to silicone gel in axillary lymph nodes after an augmentation mammaplasty. Plast Reconstr Surg 62:381
Heggers JP, Kossovsky N, Parsons RW, Robson MC, Pelley RP, Raine TJ(1983) Biocompatibility of silicone implants. Ann Plast Surg 11:38
Kumagai Y, Shiokawa Y, Medsger TA, Rodnan GP (1984) Clinical spectrum of connective tissue disease after cosmetic surgery. Arthritis Rheum 27:1
Miyoshi K, Miyamura T, Kobayashi Y (1964) Hypergammaglobulinemia by prolonged adjuvanticity in man. Disorders developed after augmentation mammaplasty. Jpn J Med 9:2122
Nunen SA van, Gatenby PA, Basten A (1982) Postmammaplasty connective tissue disease. Arthritis Rheum 25:694
Rees TD, Platt J, Ballantyne DL (1965) An investigation of cutaneous response to dimethylpolysiloxane (silicone liquid) in animals and humans — a preliminary report. Plast Reconstr Surg 35:131
Rees TD, Ballantyne DL, Seidman I (1967) Visceral response to subcutaneous and intraperitoneal injections of silicone in mice. Plast Reconstr Surg 39:402
Sergott TJ, Limoli JP, Baldwin CM, Laub DR (1986) Human adjuvant disease, possible autoimmune disease after silicone implantation: a review of the literature, case studies, and speculation for the future. Plast Reconstr Surg 78:104
Vargas A (1979) Shedding of silicone particles from inflated coeast implants (letter). Plast Reconstr Surg 64:252
Weiner SR, Paulus HE (1986) Chronic arthropathy occurring after augmentation mammaplasty. Plast Reconstr Surg 77:185
Weisman MH, Vecchione TR, Albert D, Moore LT, Mueller MR (1988) Connective-tissue disease following coeast augmentation: a preliminary test of the human adjuvant disease hypothesis. Plast Reconstr Surg 82:626
References
Brantley SK et al (1990) Assessment of the lymphocyte response to silicone. Plast Reconstr Surg 86:1131–1137
FDA (1990) Background information on the possible health risks of silicone coeast implants, December 18
Freund J (1956) Mode of action of immunological adjuvants. Adv Tuberc Res 7:130
Frey P, Lemperle G (1991) Silikonome und rheumatoide Symptomatik —eine bekannte and eine fragliche Komplikation von Silikon-Implantaten. Dtsch Ärztebl (in press)
Rose NR (1990) Letter to the FDA (Re: 88N-0244), September 12
Wilflingseder A, Probst A, Mikuz G (1974) Constrictive ficoosis following silicone implants in mammary augmentation. Chir Plast 2:215–229
References
Editorial (1991) Lancet 337:332–333
Sergott TJ, Limoli JP, Baldwin CM jr, Laub DR (1986) Human adjuvant disease, possible autoimmune disease after silicone implantation: a review of the literature, case studies, and speculation for the future. Plast Reconstr Surg 78:104–114
Weisman MH, Vecchione TR, Albert D, Moore LT, Mueller MR (1988) Connective-tissue disease following coeast augmentation: a preliminary test of the human adjuvant disease hypothesis. Plast Reconstr Surg 82:626–630
References
Adler A, Etzion Z, Berlyne G (1986) Uptake, distribution and excretion of 31silicone in normal excretion of 31silicone in normal rats. Am J Physiol 251: E670–673
Debbie JW, Smith MJ (1982) The silicone content of body fluids. J Sci Med 27:17–19
Jennings D, Morykwas M, DeFranzo A, Argenta L (in press) Analysis of silicone in human coeast and capsular tissue surrounding prostheses and expanders. Ann Plast Surg
King EJ, Stantial H, Dolan M (1933) The biochemistry of salicic acid II. The presence of salica in tissues. J Biochem27:1002–1006
Wilson J, Braunwald E, Isselbacher K, Petersorf R, Martin J, Fauci A, Root R (1991) Principles of internal medicine. McGraw-Hill
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Heredero, F.X.S., Semper, E.M. Polyarthralgia after augmentation mammaplasty with saline-filled implants. Eur J Plast Surg 15, 1–8 (1992). https://doi.org/10.1007/BF00193369
Issue Date:
DOI: https://doi.org/10.1007/BF00193369